Safinamide is a multifunctional small molecule that acts as a potent, reversible MAO-B inhibitor and glutamate release inhibitor, with additional activity on dopamine reuptake and ion channels. Its research applications include investigations for Parkinsons disease, with studies exploring its neuroprotective effects in both cellular and animal models of dopaminergic dysfunction.
